← All diseases Infectious diseases

Chronic hepatitis B

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchHighest evidence only (82)Meta-analysis (26)Treatment guideline (6)Randomized trial (32)Systematic review (10)Phase 3 study (8)Clinical trial (629)Review article (167)Early study (phase 1 or 2) (25)Description of individual patients (95)Laboratory or animal research (16)Commentary or Editorial (50)Retracted publication (2) Studies currently recruiting participants only (31)

Filter

Publications and studies (1998)

• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Immunotherapy for virus-related hepatocellular carcinoma: recent progress and future directions. (2026/12/01) ♡
• Recombinant polyclonal antibody GIGA-2339 potently and pan-genotypically neutralizes hepatitis B virus. (2026/09/01) ♡
• Hepatocellular carcinoma development after hepatitis B surface antigen seroclearance in chronic hepatitis B patients: a 10-year single-center cohort study. (2026/09/01) ♡
• Differential Hepatitis B Surface Antigen Glycan Isomer Kinetics Between Tenofovir Alafenamide and Entecavir: Hepatocellular Carcinoma Risk Stratification in Hepatitis B e Antigen-Positive Patients. (2026/09/01) ♡
• Validation of a Point-Of-Care Ultrasound for Hepatitis Among Front-Line Healthcare Workers Managing Chronic Hepatitis B Virus Infection in Zambia. (2026/09/01) ♡
• Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Prevalence of Hepatitis B Virus Infection in Cameroon: A Systematic Review and Meta-Analysis. (2026/09/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Treatment of Viral Infections During Pregnancy: Part 2: Human Immunodeficiency Virus and Viral Hepatitis. (2026/09/01) ♡
• [Analysis of influencing factors associated with cirrhosis in patients with indeterminate-phase chronic hepatitis B]. (2026/08/11) ♡
• BEAT-B Study (Behavior, Aspirations, and Treatment Needs): A Mixed-Methods Study of Patient Values, Preferences, and Barriers to Care Among People Living With Chronic Hepatitis B in South and Southeast Asia. (2026/08/09) ♡
• HBV RNA, HBcrAg, and HBsAg levels at year 6 do not predict HCC risk in patients with cirrhosis on long-term entecavir therapy. (2026/08/08) ♡
• Association of baseline anti-Ro52 seropositivity with connective tissue disease development following interferon-α therapy in patients with chronic hepatitis B. (2026/08/07) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The interplay between chronic inflammation and tumorigenesis: unraveling the inflammation-driven axis. (2026/08/07) ♡
• Mathematical Modeling of HDV RNA, HBV DNA, and HBsAg Dynamics During Lonafarnib-Based Therapy: Insights from the LOWR HDV-1 Study. (2026/08/06) ♡
• C1R suppresses hepatocellular carcinoma cell aggressiveness through promoting HIF-1α degradation and modulating cuproptosis-related protein expression. (2026/08/06) ♡
• β-glucan particles as oral carriers for a dual-antigen hepatitis B vaccine: Liver targeting and immune potentiation following subcutaneous priming. (2026/08/06) ♡
• HBsAg isoforms predict HBsAg seroclearance and finite treatment in patients with chronic hepatitis B after cessation of long term nucleos(t)ide analogue. (2026/08/06) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Viral load rather than transaminase: an international perspective on the KASL-EALA 2026 guideline for chronic hepatitis B. (2026/08/05) ♡
• Bepirovirsen induces innate immune proteins independent of HBV. (2026/08/04) ♡
• Genomic Landscape of Phenotypes Causally Associated with Night Shift Work. (2026/08/04) ♡
• Supramolecular Self-Assembly of Lycorine with Glycyrrhizic Acid into a Nanodrug for Safe and Sustained Anti-HBV Therapy. (2026/08/03) ♡
• Dynamic changes in non-invasive fibrosis scores as early predictors of deterioration in chronic hepatitis B. (2026/08/03) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. National guideline for hepatitis B elimination in Thailand: a decentralized health system model for expanding diagnosis and treatment. (2026/08/03) ♡
• Droplet Digital PCR Measurement of HBV DNA in On-Treatment Chronic HBV Patients: Association With HCC Development and Outcomes. (2026/08/01) ♡
• High Rates of Advanced Chronic Liver Disease in Patients With Chronic Hepatitis D Virus Infection in Uzbekistan. (2026/08/01) ♡
• An Exploratory Cost-Utility Analysis of Screening and Treating Immigrants in Canada for Hepatitis D. (2026/08/01) ♡
• Factors Associated With Surface Antigen (HBsAg) Clearance in a Spanish Cohort of Chronic Hepatitis B Patients: Influence on the Long-Term Prognosis. (2026/08/01) ♡
• Multiomics and artificial intelligence identify infection associated subtypes and prognostic signatures in hepatocellular carcinoma. (2026/08/01) ♡
• The Silent Burden of Hepatitis B-Related Stigma. (2026/08/01) ♡
• Absence of Detectable Anti-HDV Antibodies Among HBsAg-Positive Blood Donors, HIV-Infected Individuals and Patients With Chronic Hepatitis B in Sao Paulo, Brazil: Evaluation Using a Rapid Lateral Flow Assay. (2026/08/01) ♡
• Implementation of quantitative HBsAg testing in clinical microbiology laboratories in Spain: Results from a national GEHEP-SEIMC survey. (2026/08/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Gut Microbiota, Immunity, and Metabolism in the Progression From Chronic Liver Disease to Hepatocellular Carcinoma. (2026/08/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A Case of Discordant Hepatitis B Core Antibody Results Across Different Immunoassay Platforms in a Chronic HBV Patient. (2026/08/01) ♡
• ddOTs: A multiplexed quantitative ddPCR approach for resolving overlapping hepatitis B virus transcripts to decipher cccDNA-driven transcription. (2026/07/30) ♡
• The relationship between mutations in reverse transcriptase region of hepatitis B virus and progression of liver disease. (2026/07/28) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Challenges and achievements on the road to hepatitis elimination. (2026/07/28) ♡
• Evaluation of the Safety and Efficacy of SOF/VEL Treatment and Pre-treatment of TAF in Patients with Chronic Hepatitis B Virus/Hepatitis C Virus Coinfection: A Multicenter Study. (2026/07/28) ♡
• Baseline Liver Fibrosis Severity Predicts Superior HBeAg Clearance and Fibrosis Reversal following Peg-IFNα plus Nucleos(t)ide Analog Therapy in HBeAg-positive Chronic Hepatitis B Patients. (2026/07/28) ♡
• HBV PreS/S gene mutations in patients with chronic hepatitis B. (2026/07/25) ♡
• Chronic hepatitis B in a large private hospital network in Türkiye: Clinical characteristics and electronic health record-data gaps. (2026/07/25) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Artificial Intelligence and Generative Models in Hepatology: From Large Language Models to Digital Pathology in Liver Disease Diagnosis and Treatment. (2026/07/23) ♡
• Efficacy and safety of tenofovir alafenamide in HBeAg-positive and negative chronic hepatitis B patients aged over 30 years with normal ALT and detectable HBV DNA: a 96-week retrospective two-center study. (2026/07/23) ♡
• Solitary Brain Metastasis From Hepatocellular Carcinoma Masquerading as Acute Ischaemic Stroke: Radiological Diagnosis and Clinical Implications. (2026/07/22) ♡
• Impact of Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide or Entecavir in Older Patients with Chronic Hepatitis B. (2026/07/21) ♡
• Bepirovirsen Brings Functional Cure Closer to Reality in Chronic Hepatitis B. (2026/07/21) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Case Report: Primary Central Nervous System Lymphoma With "Wine Glass" Sign Presenting as Somnolence and Fatigue. (2026/07/20) ♡
• Chronic HBV Infection Disrupts CCL5-Secreting cNK Cells and Attenuates Liver Accumulation and Activation of DCs and HBV-Specific T Cells. (2026/07/20) ♡
• LIMITED DIAGNOSTIC ACCURACY OF FIB-4 FOR DETECTING SIGNIFICANT LIVER FIBROSIS IN CHRONIC HEPATITIS B: A CROSS-SECTIONAL STUDY. (2026/07/20) ♡
• [Distribution of serum HBV RNA in the natural history of chronic HBV infection and factors influencing HBV RNA negativity: a retrospective study stratified by HBeAg status]. (2026/07/20) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. [Clinical significance and occurrence mechanism of hepatitis B virus DNA integration]. (2026/07/20) ♡
• [APASL clinical practice guidelines on the management of chronic hepatitis B infection: a 2026 update]. (2026/07/20) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.